Structure (Structure)
Spironolactone Tablet, Film Coated
Product Images NDC 72162-1694
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 72162-1694). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure01 (Fig01)
Spironolactone appears to have a statistically significant effect, as indicated by the p-value of less than 0.001. The number of participants who received Spironolactone was 82, while the number of participants who received placebo was 841. The study duration was 2 months.*
Figure02 (Fig02)
Label (Lbl721621694)
This is a description of a medication called Spironolactone Tablets. Each film-coated tablet contains 50 mg of Spironolactone, USP. It is important to keep this medication out of reach of children and store it at a temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted to 15°C to 30°C (59°F to 86°F). The medication should be protected from light and dispensed in a tight, light-resistant container with a child-resistant closure. The pharmacist should provide instructions for use and it is recommended to visit the website "https://dailymed.nim.nih.gov/dailymed/" for more information. The medication is manufactured by Bryant Ranch Prepack, Inc. and relabeled by Jubilant Generics Limited.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
